WALTHAM, Mass., Nov. 9, 2011 (GLOBE NEWSWIRE) -- BG Medicine, Inc. (Nasdaq:BGMD), a company focused on the development and commercialization of novel, biomarker-based diagnostics, announced today that it will present at the upcoming Lazard Capital Markets 2011 8th Annual Healthcare Conference on November 15, 2011 at 10:30 a.m. Eastern Time. Pieter Muntendam, M.D., President and CEO of the Company, will present an overview of BG Medicine and updates on the Company’s cardiovascular portfolio.
